- Corporate Officers - L
- Leiden Jeffrey M
Insider Trading History of Leiden Jeffrey M
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Leiden Jeffrey M since 2006.
This trader's CIK number is 1242825.
At the time of last reporting, Leiden Jeffrey M was the Executive Chairman of Vertex Pharmaceuticals Inc / Ma. (stock ticker symbol VRTX).
Also see all insider trading activities at Vertex Pharmaceuticals Inc / Ma.
Note that in the past
LEIDEN JEFFREY M also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Abbott Laboratories (ABT) by Leiden Jeffrey M
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2006 | ABT | 0 | $0 | 2,000 | $88,820 | 83,544 | $2,776,250 |
Yearly summary of insider trading at Quest Diagnostics Inc (DGX) by Leiden Jeffrey M
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2018 | DGX | 0 | $0 | 1,644 | $173,622 | 0 | $0 |
2017 | DGX | 0 | $0 | 1,600 | $173,353 | 0 | $0 |
2016 | DGX | 0 | $0 | 6,345 | $543,296 | 6,641 | $464,079 |
Yearly summary of insider trading at Vertex Pharmaceuticals Inc / Ma (VRTX) by Leiden Jeffrey M
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2024 | VRTX | 0 | $0 | 16,188 | $7,088,643 | 0 | $0 |
2023 | VRTX | 0 | $0 | 39,278 | $14,730,919 | 0 | $0 |
2022 | VRTX | 0 | $0 | 147,868 | $41,728,833 | 60,342 | $5,494,139 |
2020 | VRTX | 0 | $0 | 385,661 | $104,088,650 | 265,603 | $35,260,125 |
2019 | VRTX | 0 | $0 | 469,566 | $88,333,562 | 416,319 | $41,422,804 |
2018 | VRTX | 0 | $0 | 239,774 | $38,129,667 | 206,063 | $13,549,833 |
2017 | VRTX | 0 | $0 | 680,892 | $94,200,506 | 482,572 | $19,960,765 |
2016 | VRTX | 0 | $0 | 9,834 | $899,201 | 0 | $0 |
2015 | VRTX | 0 | $0 | 64,500 | $7,756,898 | 0 | $0 |
2014 | VRTX | 0 | $0 | 330,961 | $34,836,003 | 245,000 | $7,345,100 |
2013 | VRTX | 0 | $0 | 43,179 | $2,172,131 | 0 | $0 |
2010 | VRTX | 2,600 | $100,100 | 0 | $0 | 0 | $0 |
Insider trading activities at 3 companies by Leiden Jeffrey M:
1. Abbott Laboratories (ABT)
2. Quest Diagnostics Inc (DGX)
3. Vertex Pharmaceuticals Inc / Ma (VRTX)
Table 1. Insider trading of Abbott Laboratories (ABT) by Leiden Jeffrey M
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2006-02-17 | ABT | Sale | 2,000 | 44.41 | 88,820 |
2006-01-31 | ABT | Option Ex | 83,544 | 33.23 | 2,776,250 |
Table 2. Insider trading of Quest Diagnostics Inc (DGX) by Leiden Jeffrey M
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2018-05-29 | DGX | Sale | 1,644 | 105.61 | 173,622 |
2017-08-04 | DGX | Sale | 296 | 106.66 | 31,571 |
2017-07-27 | DGX | Sale | 1,304 | 108.73 | 141,782 |
2016-08-03 | DGX | Option Ex | 6,641 | 69.88 | 464,079 |
2016-08-03 | DGX | Sale | 6,345 | 85.63 | 543,296 |
Table 3. Insider trading of Vertex Pharmaceuticals Inc / Ma (VRTX) by Leiden Jeffrey M
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2024-08-30 | VRTX | Sale | 3,784 | 499.00 | 1,888,216 |
2024-02-14 | VRTX | Sale | 4,356 | 419.04 | 1,825,338 |
2024-02-15 | VRTX | Sale | 4,655 | 419.16 | 1,951,189 |
2024-02-12 | VRTX | Sale | 2,656 | 419.81 | 1,115,002 |
2024-02-13 | VRTX | Sale | 737 | 419.13 | 308,898 |
2023-12-13 | VRTX | Sale | 13,354 | 399.80 | 5,338,929 |
2023-10-16 | VRTX | Sale | 12,962 | 374.00 | 4,847,788 |
2023-05-08 | VRTX | Sale | 1,125 | 349.00 | 392,625 |
2023-05-05 | VRTX | Sale | 879 | 349.84 | 307,509 |
2023-05-02 | VRTX | Sale | 6,450 | 351.05 | 2,264,253 |
2023-05-03 | VRTX | Sale | 4,508 | 350.45 | 1,579,815 |
2022-07-25 | VRTX | Sale | 132,079 | 281.39 | 37,165,181 |
2022-07-25 | VRTX | Option Ex | 60,342 | 91.05 | 5,494,139 |
2022-04-13 | VRTX | Sale | 15,789 | 289.04 | 4,563,652 |
2020-06-30 | VRTX | Sale | 32,792 | 287.72 | 9,434,914 |
2020-05-12 | VRTX | Option Ex | 88,532 | 132.75 | 11,753,065 |
2020-05-12 | VRTX | Sale | 94,370 | 283.07 | 26,713,127 |
2020-05-07 | VRTX | Option Ex | 88,534 | 132.75 | 11,753,331 |
2020-05-07 | VRTX | Sale | 94,369 | 270.02 | 25,481,517 |
2020-05-05 | VRTX | Sale | 94,372 | 269.77 | 25,458,640 |
2020-05-05 | VRTX | Option Ex | 88,537 | 132.75 | 11,753,729 |
2020-02-25 | VRTX | Sale | 10,550 | 233.73 | 2,465,893 |
2020-02-18 | VRTX | Sale | 11,685 | 243.71 | 2,847,798 |
2020-02-11 | VRTX | Sale | 47,523 | 245.92 | 11,686,761 |
2019-11-19 | VRTX | Option Ex | 96,534 | 120.52 | 11,633,795 |
2019-11-19 | VRTX | Sale | 96,534 | 211.53 | 20,419,837 |
2019-11-18 | VRTX | Option Ex | 4,434 | 120.52 | 534,363 |
2019-11-18 | VRTX | Sale | 4,434 | 210.00 | 931,140 |
2019-11-15 | VRTX | Sale | 5,000 | 210.00 | 1,050,000 |
2019-11-15 | VRTX | Option Ex | 5,000 | 120.52 | 602,575 |
2019-10-22 | VRTX | Option Ex | 107,831 | 120.52 | 12,995,252 |
2019-10-22 | VRTX | Sale | 107,831 | 190.00 | 20,487,890 |
2019-06-18 | VRTX | Sale | 56,030 | 175.72 | 9,845,591 |
2019-06-18 | VRTX | Option Ex | 56,030 | 77.31 | 4,331,679 |
2019-05-24 | VRTX | Option Ex | 113,432 | 77.31 | 8,769,427 |
2019-05-24 | VRTX | Sale | 113,432 | 175.10 | 19,861,943 |
2019-05-06 | VRTX | Sale | 33,058 | 175.01 | 5,785,645 |
2019-05-06 | VRTX | Option Ex | 33,058 | 77.31 | 2,555,713 |
2019-02-19 | VRTX | Sale | 20,997 | 187.61 | 3,939,310 |
2019-02-04 | VRTX | Sale | 32,250 | 186.43 | 6,012,206 |
2018-06-22 | VRTX | Option Ex | 106,500 | 83.36 | 8,877,840 |
2018-06-22 | VRTX | Sale | 140,211 | 160.00 | 22,433,760 |
2018-01-16 | VRTX | Sale | 99,563 | 157.65 | 15,695,907 |
2018-01-16 | VRTX | Option Ex | 99,563 | 46.92 | 4,671,993 |
2017-12-11 | VRTX | Sale | 125,000 | 141.81 | 17,726,875 |
2017-07-31 | VRTX | Option Ex | 11,063 | 45.11 | 499,051 |
2017-07-31 | VRTX | Sale | 11,063 | 153.18 | 1,694,630 |
2017-07-21 | VRTX | Sale | 32,250 | 159.86 | 5,155,420 |
2017-07-19 | VRTX | Sale | 184,374 | 161.00 | 29,684,214 |
2017-07-19 | VRTX | Option Ex | 184,374 | 46.92 | 8,651,749 |
2017-06-02 | VRTX | Option Ex | 147,101 | 41.91 | 6,165,738 |
2017-06-02 | VRTX | Sale | 147,101 | 129.50 | 19,049,579 |
2017-04-28 | VRTX | Option Ex | 140,034 | 33.16 | 4,644,227 |
2017-04-28 | VRTX | Sale | 157,200 | 119.50 | 18,785,400 |
2017-02-13 | VRTX | Sale | 23,904 | 88.03 | 2,104,388 |
2016-02-03 | VRTX | Sale | 9,834 | 91.44 | 899,201 |
2015-11-18 | VRTX | Sale | 16,125 | 130.00 | 2,096,250 |
2015-10-30 | VRTX | Sale | 16,125 | 125.24 | 2,019,462 |
2015-02-18 | VRTX | Sale | 32,250 | 112.91 | 3,641,186 |
2014-12-15 | VRTX | Sale | 50,017 | 116.65 | 5,834,483 |
2014-09-30 | VRTX | Option Ex | 200,000 | 29.98 | 5,996,000 |
2014-09-30 | VRTX | Sale | 200,000 | 112.63 | 22,526,000 |
2014-02-07 | VRTX | Sale | 35,944 | 80.00 | 2,875,520 |
2014-01-16 | VRTX | Sale | 45,000 | 80.00 | 3,600,000 |
2014-01-16 | VRTX | Option Ex | 45,000 | 29.98 | 1,349,100 |
2013-12-12 | VRTX | Sale | 9,834 | 65.48 | 643,930 |
2013-02-06 | VRTX | Sale | 33,345 | 45.83 | 1,528,201 |
2010-05-04 | VRTX | Buy | 1,300 | 38.40 | 49,920 |
2010-04-23 | VRTX | Buy | 1,300 | 38.60 | 50,180 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Leiden Jeffrey M
(Executive Chairman of Vertex Pharmaceuticals Inc / Ma at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.